Gateway Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.76M Buy
4,087
+3,011
+280% +$3.05M 0.15% 165
2025
Q4
$1.16M Sell
1,076
-143
-12% -$137K 0.13% 165
2025
Q3
$930K Sell
1,219
-28
-2% -$20.8K 0.13% 166
2025
Q2
$972K Buy
1,247
+283
+29% +$220K 0.18% 123
2025
Q1
$796K Sell
964
-12
-1% -$9.98K 0.18% 128
2024
Q4
$753K Buy
976
+285
+41% +$236K 0.2% 113
2024
Q3
$613K Sell
691
-108
-14% -$97.1K 0.17% 132
2024
Q2
$723K Buy
799
+25
+3% +$20K 0.22% 105
2024
Q1
$602K Buy
774
+10
+1% +$7.12K 0.22% 106
2023
Q4
$445K Buy
764
+177
+30% +$103K 0.18% 116
2023
Q3
$315K Hold
587
0.06% 184
2023
Q2
$275K Sell
587
-7
-1% -$2.94K 0.05% 190
2023
Q1
$204K Buy
594
+1
+0.2% +$337 0.03% 212
2022
Q4
$217K Buy
+593
New +$210K 0.04% 183

Other funds holding LLY

Gateway Wealth Partners's LLY Position: Q1 2026 in Review

Gateway Wealth Partners increased its Eli Lilly (LLY) stake by 280% in Q1 2026, buying an estimated $3.05M and bringing the position to 4,087 shares worth $3.76M. The position accounts for 0.15% of the portfolio, ranked #165.

Gateway Wealth Partners first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Gateway Wealth Partners held 4,087 shares of Eli Lilly worth $3.76M as of Q1 2026.
  • Gateway Wealth Partners bought 3,011 Eli Lilly shares in Q1 2026, an estimated $3.05M.
  • Eli Lilly made up 0.15% of Gateway Wealth Partners's portfolio in Q1 2026, its #165 holding.
  • Gateway Wealth Partners first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Gateway Wealth Partners's 13F filing for Q1 2026, filed 15 May 2026.